From NYU Langone Medical Center:
Enhancing Studies on a Possible Blood Biomarker for Traumatic Brain Injury
NYU Langone Medical Center Introducing New Technology to Identify Head Injuries at Earliest Possible Stages
February 27, 2015 (9:00AM)
New technology being introduced at NYU Langone Medical Center could help researchers advance blood biomarker capabilities that show changes in low concentrations of specific proteins present following a neurological injury.
The single molecule array (Simoa) technology developed by Quanterix, and the fully automated HD-1 analyzer, offers unprecedented improvement in sensitivity proteins over current technologies for the detection of blood-based biomarkers – as much as 1000 times more sensitive than conventional immunoassays. Specifically, it allows for more effective measurement of low concentration of proteins such as tau, a normal protein that is released from brain cells following a brain injury.
View original post 651 more words